Abstract
The Nobel Prize in Physiology or Medicine, 2019 was awarded jointly to William G. Kaelin Jr. of Dana-Farber Cancer Institute, Sir Peter J. Ratcliffe of Francis Crick Institute and University of Oxford and Gregg L. Semenza of Johns Hopkins University for their discovery of how cells sense and respond to varying oxygen levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Suggested Reading
G L Semenza, M K Nejfelt, S M Chi, and S E Antonarakis, Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene, Proc Natl Acad Sci U S A., Vol.88, pp.5680–5684, 1991b.
G L Semenza and G L Wang, A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation, Mol. Cell Biol., Vol.12, pp.5447–5454, 1992.
G L Wang and G L Semenza, General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia, Proc Natl Acad Sci USA., Vol.90, pp.4304–4308, 1993.
G L Wang and G L Semenza, Purification and characterization of hypoxia-inducible factor 1, J Biol Chem., Vol.270, pp.1230–1237, 1995.
J C Chappell, L B Payne and W K Rathmell, Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers, J Clin Invest, Vol.129 pp.442–451, 2019.
S Salceda and J Caro, Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes, J Biol Chem., Vol.272, pp.22642–22647, 1997.
P H Maxwell, M S Wiesener, G W Chang, S C Clifford, E C Vaux, M E Cockman, C C Wykoff, C W Pugh, E R Maher and P J Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, Vol.399, pp.271–275, 1999.
P Jaakkola, D R Mole, Y M Tian, M I Wilson, J Gielbert, S J Gaskell, A von Kriegsheim, H F Hebestreit, M Mukherji, C J Schofield, P H Maxwell, C W Pugh and P J Ratcliffe, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, Vol.292, pp.468–472, 2001.
M Ivan, K Kondo, H Yang, W Kim, J Valiando, M Ohh, A Salic, J M Asara, W S Lane and W G Kaelin Jr, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, Vol.292 pp.464–468, 2001.
G L Semenza, Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology, Annu Rev Pathol., Vol.9, pp.47–71, 2014.
N Chen, C Hao, B C Liu BC, H Lin, C Wang, C Xing, X Liang, G Jiang, Z Liu, X Li, L Zuo, L Luo, J Wang, M H Zhao, Z Liu, G Y Cai, L Hao, R Leong, C Wang, C Liu, T Neff, L Szczech and K P Yu, Roxadustat treatment for anemia in patients undergoing long-term dialysis, N Engl J Med, Vol.381, pp.1011–1022, 2019.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mamatha M. Reddy is a scientist at LV Prasad Eye Institute, Bhubaneswar. She received her PhD in Biochemistry from the Indian Institute of Science, Bengaluru and did a postdoctoral fellowship at Dana-Farber Cancer Institute, Boston. Mamatha Reddy is a cancer biologist with interest in understanding molecular mechanisms of retinoblastoma tumor progression.
Rights and permissions
About this article
Cite this article
Reddy, M.M. Nobel Prize in Physiology or Medicine 2019. Reson 24, 1375–1380 (2019). https://doi.org/10.1007/s12045-019-0904-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12045-019-0904-3